NEWS NEWS NEWS
IDS Breathes New Life into Medical Diagnostic Testing
Toronto, Ontario--
Caduceon Inc., the biotechnology division of IDS Intelligent
Detection Systems (T.ISD), is launching the first ever, automated
breath analysis technology, at the Ontario Hospital Association's
annual convention and exhibition today November 22nd and 23rd in
Toronto.
"We have adapted IDS' core sensory technology to develop this
breakthrough technology and expect it to greatly enhance the
speed and accuracy of medical diagnosis and to significantly
reduce its cost," says Graham Strachan, chairman, of Caduceon.
Breath analysis can provide a vast amount of information about
metabolic processes in the body-more than 400 volatile organic
compounds related to disease states such as diabetes, cardiac
disorders and liver dysfunction have been identified in human
breath. In the past, breath analysis technology has been
complicated by technological barriers, at the start of the
process-often, water must be removed from the sample because it
can create physical and chemical interference.
"With IDS technology there is no need for water removal and the
sensitivity of this equipment permits analysis from a normal
breath sample," says Strachan. "Caduceon's breath analyzer will
give medical professionals an accurate, cost-effective, portable
and reliable tool to immediately gauge the metabolic state of
their patients."
The technology has immediate use in point-of-care settings, such
as emergency rooms and intensive care units, where it will help
physicians gather crucial information in seconds. The healthcare
applications will grow as the population ages. Dr. Mariusz Rybak,
chairman and CEO, IDS believes the technology's applications
extend beyond healthcare: "There is already an emerging demand
for this kind of analysis in the fitness and alternative health
markets," he says. "and it's speed and accuracy could have uses
in other fields like occupational health and safety and law
enforcement."
Graham Strachan, who was appointed chairman of Caduceon in
October after 20 years experience in the Canadian biosciences
industry, is excited about Caduceon's future: "I have great faith
in Caduceon's ability to innovate and become a leader in the life
sciences sector," says Strachan.
IDS is a dynamic developer, manufacturer and marketer of
sophisticated detection devices and systems. The company operates
through seven business units: Analytical & Security products and
solutions, IDS Power Control Systems, Scintrex Earth Science
Instrumentation, Survey & Exploration Technology Services, IEC
(Integration, Engineering and Consulting), ChemiCorp
International and Caduceon Inc. Its more than 70 products range
from drug and explosive detectors to nuclear safety control
instruments, oil and gas exploration and developing technologies
for industrial process control and point-of-care health analysis.
-30-
For further information:
For IDS media inquiries: For IDS investor inquiries:
Louise Armstrong Rick Conroy
Advance Planning & Communications Lexington Communications
(416) 967-3702 (416) 588-1888
For U.S. inquiries:
Michael Block/Tom Dean
Murdock Capital Partners
(212) 421-2545 |
